EP3875085
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.11.2019:
19.6.2024:
19880770.3
:
31.10.2039
:
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
1.11.2019
19.6.2024
:
Mitsubishi Tanabe Pharma Corporation:
3-2-10, Dosho-machi, Chuo-ku,, Osaka-shi, Osaka 541-8505, JP
:
HAYAMA, Tetsuo:
Osaka-shi, Osaka 541-8505, JP
:
TAKAHASHI, Tomohiro:
Osaka-shi, Osaka 541-8505, JP
:
OMURA, Tomoyuki:
Osaka-shi, Osaka 541-8505, JP
:
HAYASHI, Kouji:
Osaka-shi, Osaka 541-8505, JP
:
MATSUDA, Munetomo:
Osaka-shi, Osaka 541-8505, JP
:
MIYAZAWA, Tadashi:
Osaka-shi, Osaka 541-8505, JP
:
2018207646:
2.11.2018:
JP
:
JP2019043013:
1.11.2019
:
A61K 9/10, A61K 31/4152, A61K 47/32, A61K 47/36, A61K 47/38, A61P 21/02, A61P 25/28